{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:38:59Z","timestamp":1789439939590,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015277","name":"Roche UK Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2026.107029","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:12:17Z","timestamp":1769533937000},"page":"107029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Incidence of multiple sclerosis in UK general practice; Risk of infections and mortality"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-6306","authenticated-orcid":false,"given":"Ana","family":"Ruigomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminderjit Kaur","family":"Jayia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Alberto","family":"Garcia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107029_bib0001","unstructured":"www.cprd.com\/primary-care-data-public-health-research."},{"key":"10.1016\/j.msard.2026.107029_bib0002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"Alonso","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107029_bib0003","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s00415-007-0602-z","article-title":"Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort","volume":"254","author":"Alonso","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107029_bib0004","series-title":"The Multiple Sclerosis International Federation","year":"2020"},{"issue":"4","key":"10.1016\/j.msard.2026.107029_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.21630","article-title":"Opportunistic infections and other risks with newer multiple sclerosis therapies","volume":"65","author":"Berger","year":"2009","journal-title":"Ann Neurol;"},{"issue":"3","key":"10.1016\/j.msard.2026.107029_bib0006","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/13524585221129963","article-title":"Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis","volume":"29","author":"Calocer","year":"2023","journal-title":"Mult. Scler. J."},{"issue":"3","key":"10.1016\/j.msard.2026.107029_bib0007","article-title":"Non-infectious comorbidity in patients with multiple sclerosis: a national cohort study in Sweden","volume":"6","author":"Castelo-Branco","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"3","key":"10.1016\/j.msard.2026.107029_bib0008","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"issue":"10","key":"10.1016\/j.msard.2026.107029_bib0009","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1212\/WNL.0000000000007043","article-title":"Validation of an algorithm for identifying MS cases in administrative health claims datasets","volume":"92","author":"Culpepper","year":"2019","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.msard.2026.107029_bib0010","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ana.25247","article-title":"Prodromal symptoms of multiple sclerosis in primary care","volume":"83","author":"Disanto","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107029_bib0011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/PROM.S148387","article-title":"Comorbidity in US patients with multiple sclerosis","volume":"9","author":"Edwards","year":"2018","journal-title":"Patient. Relat. Outcome Meas."},{"issue":"8","key":"10.1016\/j.msard.2026.107029_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105207","article-title":"Causes of death among commercially insured multiple sclerosis patients in the United States","volume":"9","author":"Goodin","year":"2014","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107029_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40259-018-0327-9","article-title":"Monoclonal antibodies for multiple sclerosis: an update","volume":"33","author":"Graf","year":"2019","journal-title":"BioDrugs"},{"issue":"11","key":"10.1016\/j.msard.2026.107029_bib0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-017-0800-8","article-title":"Infections in patients receiving multiple sclerosis disease-modifying therapies","volume":"17","author":"Grebenciucova","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2026.107029_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-publhealth-031914-122559","article-title":"Statistical foundations for model-based adjustments","volume":"36","author":"Greenland","year":"2015","journal-title":"Annu. Rev. Public Health"},{"issue":"1","key":"10.1016\/j.msard.2026.107029_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.msard.2026.107029_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107029_bib0018","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/CLEP.S164456","article-title":"Sampling strategies for selecting general population comparison cohorts","volume":"10","author":"Heide-J\u00f8rgensen","year":"2018","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.msard.2026.107029_bib0019","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.msard.2026.107029_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the general practice research database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.msard.2026.107029_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad065","article-title":"Infections among individuals with multiple sclerosis, Alzheimer's disease and Parkinson's disease","volume":"5","author":"Hu","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.msard.2026.107029_bib0022","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.msard.2026.107029_bib0023","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00415-015-7796-2","article-title":"Epidemiology of multiple sclerosis: results from a large observational study in the UK","volume":"262","author":"Jick","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107029_bib0024","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00415-014-7370-3","article-title":"Mortality of patients with multiple sclerosis: a cohort study in UK primary care","volume":"261","author":"Jick","year":"2014","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107029_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0902","article-title":"Associations of alcohol consumption and smoking with disease risk and neurodegeneration in individuals with multiple sclerosis in the United Kingdom","volume":"5","author":"Kleerekooper","year":"2022","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.msard.2026.107029_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104583","article-title":"Comparing the risk of serious infections in patients with and without MS:A German claims data analysis","volume":"72","author":"Knapp","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2026.107029_bib0027","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00415-025-13112-1","article-title":"Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study","volume":"272","author":"Kuutti","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107029_bib0028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/neurosci4030019","article-title":"The probable infectious origin of multiple sclerosis","volume":"4","author":"Landry","year":"2023","journal-title":"NeuroSci"},{"key":"10.1016\/j.msard.2026.107029_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106207","article-title":"2025 Prevalence and Incidence of multiple sclerosis in the Netherlands","volume":"93","author":"Lemmens","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.107029_bib0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.107029_bib0031","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jnnp-2013-305450","article-title":"Incidence and prevalence of multiple sclerosis in the uk 1990-2010: a descriptive study in the general practice research database","volume":"85","author":"Mackenzie","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"23","key":"10.1016\/j.msard.2026.107029_bib0032","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1212\/WNL.0000000000000495","article-title":"Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality","volume":"82","author":"Marrie","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107029_bib0033","article-title":"Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments","volume":"94","author":"McGarvey Lambert","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107029_bib0034","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jamaneurol.2020.0664","article-title":"Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England","volume":"77","author":"Palladino","year":"2020","journal-title":"JAMa Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107029_bib0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamaneurol.2021.0627","article-title":"Progressive multifocal leukoencephalopathy in a patient with progressive multiple sclerosis treated with ocrelizumab monotherapy","volume":"78","author":"Patel","year":"2021","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107029_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101982","article-title":"Infections in patients diagnosed with multiple sclerosis: A multi-database study","volume":"41","author":"Persson","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107029_bib0037","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1352458520910497","article-title":"Comorbid disease burden among MS patients 1968\u20132012: a swedish register\u2013based cohort study","volume":"27","author":"Smith","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107029_bib0038","first-page":"1","article-title":"Association of multiple sclerosis with risk of mortality among a nationally representative sample of adults in the United States","author":"Titcomb","year":"2022","journal-title":"Mult. Scler. J.\u2014 Exp."},{"key":"10.1016\/j.msard.2026.107029_bib0039","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.msard.2026.107029_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/nmt.15.64","article-title":"Multiple sclerosis and infections","volume":"5","author":"Venkatesan","year":"2015","journal-title":"Neurodegener. Dis. Manage"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:53:51Z","timestamp":1780415631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S2211034826000659"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107029","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of multiple sclerosis in UK general practice; Risk of infections and mortality","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107029"}}